Bente Frolund

Copenhagen, 2100, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 69 publications

Structure-Activity Relationship for Inflammasome Inhibition by Thiomuscimol.

Structure-Activity Relationship for Inflammasome Inhibition by Thiomuscimol.

Journal: International journal of molecular sciences

Published: June 03, 2026

Exploring the DS2 Scaffold for GABAA Receptor Modulation: Progress toward the Development of a GABAA δ-Subunit Preferring Negative Allosteric Modulator.

Exploring the DS2 Scaffold for GABAA Receptor Modulation: Progress toward the Development of a GABAA δ-Subunit Preferring Negative Allosteric Modulator.

Journal: Journal of medicinal chemistry

Published: February 02, 2026

Radiofluorinated Analogs of NCS-382 as Potential PET Tracers for Imaging the CaMKIIα Hub Domain.

Radiofluorinated Analogs of NCS-382 as Potential PET Tracers for Imaging the CaMKIIα Hub Domain.

Journal: ACS chemical neuroscience

Published: June 25, 2025

Fluorescent Isostere (Fluostere) of the Carboxylate: Design of hDHODH Fluorescent Inhibitors as Proof of Concept.

Fluorescent Isostere (Fluostere) of the Carboxylate: Design of hDHODH Fluorescent Inhibitors as Proof of Concept.

Journal: Journal of medicinal chemistry

Published: June 18, 2025

Structural basis for selective inhibition of human GABA transporter GAT3.

Structural basis for selective inhibition of human GABA transporter GAT3.

Journal: Nature communications

Published: March 26, 2025

Structure-Based Virtual Screening Identifies 2-Arylthiazole-4-Carboxylic Acids as a Novel Class of Nanomolar Affinity Ligands for the CaMKIIα Hub Domain.

Structure-Based Virtual Screening Identifies 2-Arylthiazole-4-Carboxylic Acids as a Novel Class of Nanomolar Affinity Ligands for the CaMKIIα Hub Domain.

Journal: Journal of medicinal chemistry

Published: January 28, 2025

Design, Synthesis, and Pharmacological Evaluation of Nonsteroidal Tricyclic Ligands as Modulators of GABAA Receptors.

Design, Synthesis, and Pharmacological Evaluation of Nonsteroidal Tricyclic Ligands as Modulators of GABAA Receptors.

Journal: Journal of medicinal chemistry

Published: January 14, 2025

International Union of Basic and Clinical Pharmacology. CXX. γ-Hydroxybutyrate protein targets in the mammalian brain-beyond classic receptors.

International Union of Basic and Clinical Pharmacology. CXX. γ-Hydroxybutyrate protein targets in the mammalian brain-beyond classic receptors.

Journal: Pharmacological reviews

Published: October 31, 2024

Allosteric factors in the calcium/calmodulin-responsive kinase II hub domain determine selectivity of GHB ligands for CaMKIIα.

Allosteric factors in the calcium/calmodulin-responsive kinase II hub domain determine selectivity of GHB ligands for CaMKIIα.

Journal: The Journal of biological chemistry

Published: October 25, 2024

CaMKIIα hub ligands are unable to reverse known phenotypes in Angelman syndrome mice.

CaMKIIα hub ligands are unable to reverse known phenotypes in Angelman syndrome mice.

Journal: Basic & clinical pharmacology & toxicology

Published: September 05, 2024

Ligand-induced CaMKIIα hub Trp403 flip, hub domain stacking, and modulation of kinase activity.

Ligand-induced CaMKIIα hub Trp403 flip, hub domain stacking, and modulation of kinase activity.

Journal: Protein science : a publication of the Protein Society

Published: April 10, 2024

Author Correction: Muscimol inhibits plasma membrane rupture and ninjurin-1(NINJ1) oligomerization during pyroptosis.

Author Correction: Muscimol inhibits plasma membrane rupture and ninjurin-1(NINJ1) oligomerization during pyroptosis.

Journal: Communications biology

Published: March 12, 2024

Showing 1-12 of 69

Last Updated: 09/26/2026